Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Int J Mol Sci. 2022 May 6;23(9):5214. doi: 10.3390/ijms23095214.
Despite recent scientific and technological advances, myocardial infarction (MI) still represents a major global health problem, leading to high morbidity and mortality worldwide. During the post-MI wound healing process, dysregulated immune inflammatory pathways and failure to resolve inflammation are associated with maladaptive left ventricular remodeling, progressive heart failure, and eventually poor outcomes. Given the roles of immune cells in the host response against tissue injury, understanding the involved cellular subsets, sources, and functions is essential for discovering novel therapeutic strategies that preserve the protective immune system and promote optimal healing. This review discusses the cellular effectors and molecular signals across multi-organ systems, which regulate the inflammatory and reparative responses after MI. Additionally, we summarize the recent clinical and preclinical data that propel conceptual revolutions in cardiovascular immunotherapy.
尽管最近在科学和技术方面取得了进步,但心肌梗死 (MI) 仍然是一个重大的全球健康问题,导致全球发病率和死亡率居高不下。在 MI 后的伤口愈合过程中,免疫炎症途径失调和炎症无法消退与左心室重构不良、心力衰竭进展以及最终预后不良有关。鉴于免疫细胞在宿主对抗组织损伤反应中的作用,了解相关的细胞亚群、来源和功能对于发现保护保护性免疫系统和促进最佳愈合的新治疗策略至关重要。这篇综述讨论了跨多器官系统调节 MI 后炎症和修复反应的细胞效应物和分子信号。此外,我们总结了最近的临床前和临床数据,这些数据推动了心血管免疫治疗的概念革命。